Case Report: Successful management of acute kidney injury following interventional heartworm extraction in a dog with caval syndrome
Abstract
A 12-year-old, 7 kg, castrated male, mixed-breed dog presented with lethargy, vomiting, and hemoglobinuria. Heartworm infection was diagnosed through a positive Dirofilaria immitis antigen test, thoracic radiography, and echocardiography, which revealed an extensive worm burden extending into the right atrium, right ventricle, main pulmonary artery, and caudal vena cava, indicative of caval syndrome. Interventional heartworm extraction was successfully performed via jugular venotomy, based on clinical and imaging assessments. However, within 48 h postoperatively, the dog developed acute kidney injury (AKI) characterized by oliguria, pleural effusion, and significantly elevated kidney biomarkers. Despite aggressive medical management, kidney function deteriorated, prompting two sessions of prolonged intermittent renal replacement therapy (PIRRT). After PIRRT, the dog exhibited marked clinical and biochemical improvements. Continuous follow-up demonstrated a progressive recovery of kidney function, which was supported by declining serum creatinine, blood urea nitrogen, and urinary cystatin B levels. Knowingly, this is the first documented report in the veterinary literature describing AKI secondary to caval syndrome following interventional heartworm removal in a dog that was successfully managed with PIRRT. This case underscores the necessity for early identification and management of kidney complications after heartworm extraction and highlights hemodialysis as an effective…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.